ArticleArthritis2015

Antibodies to infliximab and adalimumab in patients with rheumatoid arthritis in clinical remission: a cross-sectional study.

Grith P Eng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.